Greyson International, Inc./ US39807G1076 /
2024-04-04 9:36:43 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0001USD | - | 6,675 Turnover: .6675 |
-Bid Size: - | -Ask Size: - | 0.0001 | 0.0001 |
GlobeNewswire
9:01 AM
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00 AM
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00 AM
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00 AM
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00 AM
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00 AM
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
GlobeNewswire
7:00 AM
WISeKey Announces Retirement of Peter Ward as Chief Financial Officer; Appoints John O’Hara as its N...